135 related articles for article (PubMed ID: 32696866)
1. TMPO-AS1 is an independent prognostic factor for patients with laryngeal squamous cell carcinoma.
Zhang L; Zhang Y; Zhang C; Hou Y; Tian F
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):784-788. PubMed ID: 32696866
[TBL] [Abstract][Full Text] [Related]
2. Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients.
Mohammadrezakhani H; Baradaran B; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Safaralizadeh R
J Gastrointest Cancer; 2020 Sep; 51(3):952-956. PubMed ID: 31768869
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
Liu X; Shen Z
Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
8.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription.
Luo XJ; He MM; Liu J; Zheng JB; Wu QN; Chen YX; Meng Q; Luo KJ; Chen DL; Xu RH; Zeng ZL; Liu ZX; Luo HY
Exp Mol Med; 2022 Jun; 54(6):834-847. PubMed ID: 35760875
[TBL] [Abstract][Full Text] [Related]
11. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
Li L; Wang J; Gao L; Gong L
Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
[TBL] [Abstract][Full Text] [Related]
12. Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
He FY; Liu HJ; Guo Q; Sheng JL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):760-764. PubMed ID: 28272707
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long noncoding RNA PTPRG-AS1 is associated with poor prognosis in epithelial ovarian cancer.
Ren XY; Yang WB; Tian Y
Rev Assoc Med Bras (1992); 2020 Jul; 66(7):948-953. PubMed ID: 32844927
[TBL] [Abstract][Full Text] [Related]
14. [Expression of long non-coding RNA LINC00460 in laryngeal squamous cell carcinoma tissue and its clinical significance].
Ge SS; Wu YY; Gao W; Zhang CM; Hou J; Wen SX; Wang BQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):18-22. PubMed ID: 29798204
[No Abstract] [Full Text] [Related]
15. The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell carcinoma by stabilizing CARM1.
Qin H; Xu J; Gong L; Jiang B; Zhao W
Biochem Biophys Res Commun; 2019 Apr; 512(1):34-40. PubMed ID: 30853182
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Dai Y; Liu Y; Tian X; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer.
Zhao H; Ding F; Zheng G
FASEB J; 2020 Sep; 34(9):11382-11394. PubMed ID: 32692467
[TBL] [Abstract][Full Text] [Related]
18. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis.
Xu Z; Xi K
Biomed Pharmacother; 2019 Oct; 118():109222. PubMed ID: 31351424
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
Han L; Jiang B; Wu H; Zhang S; Lu X
Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]